Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.

@article{Ethun2018TransplantationVR,
  title={Transplantation Versus Resection for Hilar Cholangiocarcinoma: An Argument for Shifting Treatment Paradigms for Resectable Disease.},
  author={Cecilia G Ethun and Alexandra G Lopez-Aguiar and D J Anderson and Andrew B Adams and Ryan Courtney Fields and Maria B. Majella Doyle and William C. Chapman and Bradley A Krasnick and Sharon M. Weber and Joshua D. Mezrich and Ahmed I Salem and Timothy M Pawlik and George A. Poultsides and Thuy B. Tran and Kamran Idrees and Chelsea A. Isom and Robert C G Martin and Charles Raben Scoggins and Perry Shen and Harveshp Mogal and Carl R Schmidt and Eliza Wright Beal and Ioannis S Hatzaras and Rivfka Shenoy and Kenneth Cardona and Shishir Kumar Maithel},
  journal={Annals of surgery},
  year={2018},
  volume={267 5},
  pages={
          797-805
        }
}
OBJECTIVE To investigate the influence of type of surgery (transplant vs resection) on overall survival (OS) in patients with hilar cholangiocarcinoma (H-CCA). BACKGROUND Outcomes after resection for H-CCA are poor, yet transplantation is currently only reserved for well-selected patients with unresectable disease. METHODS All patients with H-CCA who underwent resection from 2000 to 2015 at 10 institutions were included. Three institutions additionally had active H-CCA transplant protocols… CONTINUE READING
Recent Discussions
This paper has been referenced on Twitter 44 times over the past 90 days. VIEW TWEETS